Lakshmishree and 3 other desks added 5 names to long-term buy lists, identifying fundamentally strong candidates for patient portfolio allocation.
Lakshmishree and 3 other registered desks issued 11 equity long term recommendations today, targeting multi-month to multi-year investment horizons. The batch carries a bullish bias — 11 buys against 0 sells — covering 5 stocks.
NARMADA was flagged for a buy by Lakshmishree at ₹33.8, targeting ₹36 — a potential upside of +6.5%.
PARAS attracted 4 separate recommendations from registered analysts — Zee Business issued a buy at ₹1,199 targeting ₹1,370; Zee Business issued a buy at ₹1,199 targeting ₹1,390; Zee Business issued a buy at ₹1,193 targeting ₹1,370; Zee Business issued a buy at ₹1,193 targeting ₹1,390.
STLTECH attracted 4 separate recommendations from registered analysts — Zee Business issued a buy at ₹502 targeting ₹580 (stop ₹425); Zee Business issued a buy at ₹502 targeting ₹655 (stop ₹425); Zee Business issued a buy at ₹506 targeting ₹580 (stop ₹425); Zee Business issued a buy at ₹506 targeting ₹655 (stop ₹425).
Also covered: SBILIFE (₹1,903.9 → ₹1,975) via Integratedresearchchannel; ADANIPORTS (₹1,740 → ₹2,000) via Ndtv Profit.
Long-term picks are best accumulated on dips. Investors should review fundamentals periodically and maintain position sizing discipline.
All recommendations reproduced here originate exclusively from SEBI-registered Research Analysts and are published for informational purposes only. These are not buy or sell recommendations from this publication. Registration with SEBI does not guarantee returns. Investing in securities markets is subject to market risks — read all related documents carefully before investing.
Disclaimer
All recommendations published on Bharatstox are sourced exclusively from SEBI-registered Research Analysts. Registration with SEBI does not guarantee returns or the performance of the intermediary. Investing in securities markets is subject to market risks. Read all related documents carefully before investing. This article is for informational purposes only and does not constitute investment advice.